Saranac Partners’s Thermo Fisher Scientific TMO Stock Holding History

Saranac Partners’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-403	Closed	-$210K	–	86
2024 Q4	$210K	Buy	+403	New	+$222K	0.12%	75
2024 Q3	–	Sell	-398	Closed	-$220K	–	64
2024 Q2	$220K	Hold	398	–	–	0.13%	70
2024 Q1	$231K	Sell	398 -582	-59%	-$327K	0.14%	73
2023 Q4	$520K	Buy	980 +30	+3%	+$14.5K	0.34%	45
2023 Q3	$481K	Sell	950 -50	-5%	-$26.6K	0.27%	37
2023 Q2	$522K	Sell	1,000 -20	-2%	-$10.8K	0.28%	37
2023 Q1	$588K	Buy	1,020 +640	+168%	+$361K	0.35%	34
2022 Q4	$209K	Buy	+380	New	+$201K	0.38%	41

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Saranac Partners's TMO Position: Q1 2025 in Review

Saranac Partners sold out of Thermo Fisher Scientific (TMO) in Q1 2025, closing a stake of 403 shares — an estimated $210K sold.

Saranac Partners first reported a position in TMO in Q4 2022 and held it in 8 quarters. The position peaked at $588K in Q1 2023. 2,570 funds tracked by Wall St. Rank hold TMO as of Q1 2025.

Saranac Partners reported no remaining Thermo Fisher Scientific position as of Q1 2025 after selling out during the quarter.
Saranac Partners sold 403 Thermo Fisher Scientific shares in Q1 2025, an estimated $210K.
Saranac Partners first reported a position in Thermo Fisher Scientific in Q4 2022 and held it in 8 quarters.
Saranac Partners's Thermo Fisher Scientific position peaked at $588K in Q1 2023.
2,570 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2025.

Based on Saranac Partners's 13F filing for Q1 2025, filed 15 Dec 2025.